DRG at AACC: Takeaways
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them questions about what makes them the worldwide leader in diagnostics. These are the key takeaways the top executives at DRG want you to remember.
Michael Martini (full profile)
We’re here to advance science, science throughout the world. One of the key products that sell is a product called Hepcidin. It’s really a novel compound where we’re one of the only companies in the world that make the diagnostic test for it. We make great products to advance the diagnostic community, and I’m proud to work for DRG. Really just excited to be here and kind of spread the word on what we can hopefully accomplish in the future here.
Wilhelm Saenger (full profile)
I hope that people get an impression, a little bit of an impression, of the people of DRG, that we would like to meet some people from DRG who work with us here and to bring out products to this country or to this clients. That would be a wonderful outcome of this.
Dr. Oleg Vishnevski
Stay with DRG. Be with us and you will be profitable.
I think it goes back to people. DRG is made form, it’s a small company, and what pushes it ahead is personality and people, culture, multi-language, everything. This is a very personal thing for me.
Dr. Witold Jurkiewicz (full profile)
Of course, this is very difficult to say in few words, but I suggest if you like to find something new, please visit DRG.
Dr. Cyril E. Geacintov (full profile)
One of the best things I liked was a couple of years ago when [inaudible 00:01:49] which is the other very big show, I had a guy, a professor, come out to me and say, “How long have you been with the company?” I said, “Well, very long.” He says, “Do you know that there was a Dr. G who formed that company?” I said, “Yes, I know that.” Then he says to me, “Did you ever meet him?” I said, “Yes, it was me.” “Oh my god,” he says, “I didn’t know that.” What I’m proud of is that instead of being a personal company, it is now a worldwide corporation, and I think the one thing to remember is that I would like it to continue because 47 years in existence, we have experienced a lot of good things, but we’ve also had downfalls. Then you pick yourself up and you start again. We have good products. We want to distribute them worldwide and we really to make sure that everybody understands that DRG is a worldwide specialty medical diagnostic business, but on top of that, we don’t hesitate to do other things either. Every day you sell something and you make a profit, it gives you a chance to continue to do business again.
Latest posts by Gregory C. Guest (see all)
- DRG CA 72-4 ELISA Kit Used in Winthrop University Study - March 15, 2017
- DRG International to Exhibit at Medlab Dubai 2017 - February 3, 2017
- DRG at AACC: Takeaways - January 12, 2017
News and Updates
DRG’s CA 72-4 ELISA Kit (EIA-5071), which uses antibodies licensed from the NIH, has been used in a recent study conducted by Winthrop University. The study used the DRG CA 72-4 ELISA Kit (EIA-5071) to explore the expression of CA72-4 compared to current FDA-approved...read more
DRG is pleased to officially announce that we are going to Medlab Dubai from February 6th-February 9th, 2017 at the Dubai International Convention & Exhibition Centre, attended by over 10,000 delegates. The conference features 11 CME-accredited conference...read more
DRG’s staff is diverse and the company maintains a global presence requiring its staff to speak multiple languages as well as travel the world visiting DRG’s many offices and events. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them each about what DRG’s strengths are and how they add value to customers and business partners. Wilhelm Saenger (full profile) Our flexibility, flexibility and...read more
As a worldwide leader in diagnostics with several locations spanning the globe, DRG is proud to have a diverse, multilingual staff. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked each of them about the languages they...read more
Maximilian Saenger, son of the General Manager of DRG Germany (Wilhelm Saenger), traveled to Bishkek, capital of Kyrgyz Republic, during his summer vacation in August 2016.read more
We sat down with top members of the DRG International team at the AACC Convention 2016 in Philadelphia, PA, US and discuss innovation in the diagnostic testing field.read more
The 25-OH Vitamin D total ELISA (EIA-5396) was recently awarded the 2015-2016 Certificate of Proficiency by the Vitamin D External Quality Assessment Scheme (DEQAS) Advisory Panel.read more
Chromogenics was first introduced to the public with the invention and patent for detecting E. coli bacteria by method of “chromogenic differentiation” culture media.read more
The DRG:HYBRID-XL fully automated random access analyzer is the perfect fit for medium or small laboratories. Its compact size can deliver to large demand and can be your primary machine to provide diagnostics to clients.read more
DRG International, Inc. recently exhibited at ENDO EXPO 2016, the largest meeting of endocrine practitioners and researchers, from April 1 – 3 at the Boston Convention & Exhibition Center in Boston, MA.read more
DRG® International, Inc. and DRG Instruments GmbH was proud to participate with our distributor Biomedix and with great success in Hospitalar 2016 In Expo-Centro Norte in Sao Paulo, Brazil, May 17-20, 2016read more